Heart failure (HF) represents the leading cause of morbidity and mortality in adult patients
with congenital heart disease. The nature of underlying congenital heart disease has …

Advances in the prevention, diagnosis, and treatment for congenital heart disease (CHD),
the most common birth defect in China, have drastically improved survival for individuals …

Aims In a continuously ageing population of patients with congenital heart disease (CHD),
understanding the long-term risk of morbidity is crucial. The aim of this study was to compare …

Aims Information on the prevalence, outcome and factors associated with heart failure in
patients with adult congenital heart disease (CHD)(ACHD‐HF) is lacking. We aimed at …

Background Patients with congenital heart disease (CHD) are at risk for the development of
low cardiac output and other physiologic derangements, which could be detected early …

Objective Limited contemporary data exist regarding outcomes and resource use among
adults with congenital heart disease and heart failure (ACHD-HF). This study compared …

Background Follow‐up at a regional adult congenital heart disease (ACHD) center is
recommended for all ACHD patients at least once per the 2018 ACC/AHA guidelines. Other …

Aims We aimed to describe the risk of myocardial infarction (MI) in middle-aged and older
patients with congenital heart disease (ACHD) and to evaluate the long-term outcomes after …

Background As patients with congenital heart disease (CHD) are living longer,
understanding the comorbidities they develop as they age is increasingly important …

The number of rTOF patients who survive into adulthood is steadily rising, with currently
more than 90% reaching the third decade of life. However, rTOF patients are not cured, but …